Abstract:Kv2.1 channel currents in pancreatic beta-cells are thought to contribute to action potential repolarization and thereby modulate insulin secretion. Because of its central role in this important physiological process, Kv2.1 channel is a promising target for the treatment of type 2 diabetes. Jingzhaotoxin-XI (JZTX-XI) is a novel peptide neurotoxin isolated from the venom of the spider Chilobrachys jingzhao. Two-microelectrode voltage clamp experiments had showed that the toxin inhibited Kv2.1 potassium currents expressed in Xenopus Laevis oocytes. In order to investigate the structure-function relationship of JZTX-XI, the natural toxin and a mutant of JZTX-XI in which Arg3 was replaced by Ala, were synthesized by solid-phase chemistry method with Fmoc-protected amino acids on the PS3 automated peptide synthesizer. Reverse-phase high performance liquid chromatography (RP-HPLC) and matrix assisted laser desorption/ ionization time-of-flight mass spectrometry (MALDI-TOF/TOF MS) were used to monitor the oxidative refolding process of synthetic linear peptides to find the optimal renaturation conditions of these toxins. The experiments also proved that the relative molecular masses of refolded peptides were in accordance with their theoretical molecular masses. RP-HPLC chromatogram of co-injected native and refolded JZTX-XI was a single peak. Under the whole-cell patch-clamp mode, JZTX-XI could completely inhibit hKv2.1 and hNav1.5 channels currents expressed in HEK293T cells with IC50 values of 95.8 nmol/L and 437.1 nmol/L respectively. The mutant R3A-JZTX-XI could also inhibit hKv2.1 and hNav1.5 channel currents expressed in HEK293T cells with IC50 values of 1.22 micromol/L and 1.96 micromol/L respectively. However, the prohibitive levels of R3A-JZTX-XI on hKv2.1 and hNav1.5 channels were reduced by about 12.7 times and 4.5 times respectively, indicating that Arg3 was a key amino acid residue relative to the hKv2.1 channel activity of JZTX-XI, but it is also an amino acid residue correlated with the binding activity of JZTX-XI to hNav1.5 channel. Our findings should be helpful to develop JZTX-XI into a molecular probe and drug candidate targeting to Kv2.1 potassium channel in the pancreas.

Loop 2 of Ophiophagus Hannah Toxin B Binds with Neuronal Nicotinic Acetylcholine Receptors and Enhances Intracranial Drug Delivery.

Pharmaceutical Optimization of Peptide Toxins for Ion Channel Targets: Potent, Selective, and Long-Lived Antagonists of Kv1.3.

Bmk Nspk, A Potent Potassium Channel Inhibitor From Scorpion Buthus Martensii Karsch, Promotes Neurite Outgrowth Via Ngf/Trka Signaling Pathway

Engineering a Peptide Inhibitor Towards the KCNQ1/KCNE1 Potassium Channel (Iks)

[Synthesis, Refolding and Identification of Pharmacological Activities of Neurotoxin JZTX-XI and R3A-JZTX-XI].

The binding of BmK abT, a unique neurotoxin, to mammal brain and insect Na+ channels using biosensor

Effects of recombinant neurotoxins on single Na+ channels in isolated rat hippocampal neurons

Isolation and Pharmacological Characterization of α-Elapitoxin-Oh3a, a Long-Chain Post-Synaptic Neurotoxin From King Cobra (Ophiophagus hannah) Venom

A Facile Approach to Functionalizing Cell Membrane-Coated Nanoparticles with Neurotoxin-Derived Peptide for Brain-Targeted Drug Delivery.

Characterization of a Membrane Binding Loop Leads to Engineering Botulinum Neurotoxin B with Improved Therapeutic Efficacy.

Molecular modeling and structural analysis of nAChR variants uncovers the mechanism of resistance to snake toxins

Structure–Activity Relationship of a Highly Selective Peptidyl Inhibitor of Kv1.3 Voltage-Gated K + -Channel from Scorpion ( B. sindicus ) Venom

Molecular Mechanism of Δ-Dendrotoxin-potassium Channel Recognition Explored by Docking and Molecular Dynamic Simulations

Investigation of binding modes of spider toxin–human voltage-gated sodium channel subtybe 1.7

Identification of nose-to-brain homing peptide through phage display.

Designer and natural peptide toxin blockers of the KcsA potassium channel identified by phage display

Cholera Toxin Subunit B Enabled Multifunctional Glioma-Targeted Drug Delivery.

Structural and Functional Characterization of a Novel Scorpion Toxin that Inhibits NaV1.8 via Interactions With the DI Voltage Sensor and DII Pore Module

Mechanisms Underlying the Inhibition of KV1.3 Channel by Scorpion Toxin ImKTX58

Overcoming the Blood-Brain Barrier for Delivering Drugs into the Brain by Using Adenosine Receptor Nanoagonist.

Ph-Responsive Polymeric-Cargo Encapsulated Magnetic Nanoparticles for Selective Release and Imaging